Skip to content
2000
Volume 20, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603

Abstract

Aim

Hepatic perivascular epithelioid cell tumors (PEComa) often mimic hepatocellular carcinoma (HCC) in patients without cirrhosis. This study aimed to develop a nomogram using imaging characteristics on Gd-EOB-DTPA-enhanced MRI and to distinguish PEComa from HCC in a non-cirrhotic liver.

Methods

Forty patients with non-cirrhotic Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) were included in our study. A multivariate logistic regression model was used to select significant variables to distinguish PEComa from HCC. A nomogram was developed based on the regression model. The performance of the nomogram was assessed with respect to the ROC curve and calibration curve. Decision curve analysis (DCA) was performed to evaluate the clinical usefulness of the nomogram.

Results

Two significant predictors were identified: the appearance of an early draining vein and the T1D value of tumors. The ROC curve showed that the area under the curve (AUC) of the model to predict the risk of PEComa was 0.91 (95% CI: 0.80~1) and showed that the model had high specificity (92.3%) and sensitivity (88.9%). The nomogram incorporating these two predictors showed favorable calibration, which was validated using 1000 resampling procedures, and the corrected C-index of this model was 0.90. Furthermore, DCA analysis showed that the model had clinical practicability.

Conclusion

In conclusion, the nomogram model showed favorable predictive accuracy for distinguishing PEComa from HCC in non-cirrhotic patients and may aid in clinical decision-making.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cmir/10.2174/0115734056269369231213102554
2024-02-27
2025-01-06
Loading full text...

Full text loading...

/deliver/fulltext/cmir/20/1/CMIR-20-E15734056269369.html?itemId=/content/journals/cmir/10.2174/0115734056269369231213102554&mimeType=html&fmt=ahah

References

  1. CalameP. TyrodeG. VerhoevenD.W. FélixS. KlompenhouwerA.J. MartinoV.D. DelabrousseE. ThévenotT. Clinical characteristics and outcomes of patients with hepatic angiomyolipoma: A literature review.World J. Gastroenterol.202127192299231110.3748/wjg.v27.i19.229934040323
    [Google Scholar]
  2. MaebayashiT. AbeK. AizawaT. SakaguchiM. IshibashiN. AbeO. TakayamaT. NakayamaH. MatsuokaS. NireiK. NakamuraH. OgawaM. SugitaniM. Improving recognition of hepatic perivascular epithelioid cell tumor: Case report and literature review.World J. Gastroenterol.201521175432544110.3748/wjg.v21.i17.543225954119
    [Google Scholar]
  3. KlompenhouwerA.J. VerverD. JankiS. BramerW.M. DoukasM. DwarkasingR.S. de ManR.A. IJzermansJ.N.M. Management of hepatic angiomyolipoma: A systematic review.Liver Int.20173791272128010.1111/liv.1338128177188
    [Google Scholar]
  4. WannasaiK. CharoenchueP. LapisatepunW. WongsuriyathaiT. KongkarnkaS. Primary hepatic perivascular epithelioid cell tumor: A case report and review of literature.Human Pathology Reports20233130069910.1016/j.hpr.2023.300699
    [Google Scholar]
  5. SeowJ. McGillM. WangW. SmithP. GoodwinM. Imaging hepatic angiomyolipomas: key features and avoiding errors.Clin. Radiol.2020752889910.1016/j.crad.2019.09.13531677881
    [Google Scholar]
  6. LiuW. WangJ. HuangQ. LuQ. LiangW. Comparison of MRI features of epithelioid hepatic angiomyolipoma and hepatocellular carcinoma: Imaging data from two centers.Front. Oncol.2018860010.3389/fonc.2018.0060030619742
    [Google Scholar]
  7. RenN. QinL.X. TangZ.Y. WuZ.Q. FanJ. Diagnosis and treatment of hepatic angiomyolipoma in 26 cases.World J. Gastroenterol.2003981856185810.3748/wjg.v9.i8.185612918138
    [Google Scholar]
  8. PetrollaA.A. XinW. Hepatic angiomyolipoma.Arch. Pathol. Lab. Med.2008132101679168210.5858/2008‑132‑1679‑HA18834230
    [Google Scholar]
  9. LiuJ. ZhangC.W. HongD.F. TaoR. ChenY. ShangM.J. ZhangY.H. Primary hepatic epithelioid angiomyolipoma: A malignant potential tumor which should be recognized.World J. Gastroenterol.201622204908491710.3748/wjg.v22.i20.490827239117
    [Google Scholar]
  10. XuG. XuH. YangH. DuS. MaoY. Primary hepatic perivascular epithelioid cell neoplasm (PEComa) with fever in a 53-year-old man.Postgrad. Med. J.202096113850550610.1136/postgradmedj‑2019‑13731532051281
    [Google Scholar]
  11. CaiP.Q. WuY.P. XieC.M. ZhangW.D. HanR. WuP.H. Hepatic Perivascular epithelioid cell tumors: CT and MR imaging findings with clinical-pathologic comparison.Abdom. Imaging20133848248910.1007/s00261‑012‑9932‑022996326
    [Google Scholar]
  12. Epidemiology of hepatocellular carcinoma - mcglynn - 2021 - hepatology.Available from: https://aasldpubs.onlinelibrary.wiley.com/ doi/10.1002/hep.31288
  13. YangL. XuZ. DongR. FanJ. DuY. ZhangY. Is surgery necessary for patients with hepatic Perivascular epithelioid cell tumors? Retrospective analysis from eight Chinese cases.J. Gastroenterol. Hepatol.2013281648165310.1111/jgh.1228923731017
    [Google Scholar]
  14. XuA.M. ZhangS.H. ZhengJ.M. ZhengW.Q. WuM.C. Pathological and molecular analysis of sporadic hepatic angiomyolipoma.Hum. Pathol.200637673574110.1016/j.humpath.2006.01.02816733215
    [Google Scholar]
  15. PengZ. LiC. ChanT. CaiH. LuoY. DongZ. LiZ.P. FengS.T. Quantitative evaluation of Gd-EOB-DTPA uptake in focal liver lesions by using T1 mapping: differences between hepatocellular carcinoma, hepatic focal nodular hyperplasia and cavernous hemangioma.Oncotarget2017839654356544410.18632/oncotarget.1891829029443
    [Google Scholar]
  16. BöttcherJ. HanschA. PfeilA. SchmidtP. MalichA. SchneeweissA. MaurerM.H. StreitparthF. TeichgräberU.K. RenzD.M. Detection and classification of different liver lesions: Comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation.Eur. J. Radiol.201382111860186910.1016/j.ejrad.2013.06.01323932636
    [Google Scholar]
  17. YanZ. GrenertJ.P. JosephN.M. RenC. ChenX. ShafizadehN. KakarS. Hepatic angiomyolipoma: mutation analysis and immunohistochemical pitfalls in diagnosis.Histopathology201873110110810.1111/his.1350929512829
    [Google Scholar]
  18. LowS.C.S. PehW.C.G. MuttarakM. CheungH.S. NgI.O.L. Imaging features of hepatic angiomyolipomas.J. Med. Imaging Radiat. Oncol.200852211812310.1111/j.1440‑1673.2008.01927.x18373801
    [Google Scholar]
  19. LeeS.J. KimS.Y. KimK.W. KimJ.H. KimH.J. LeeM.G. YuE.S. Hepatic angiomyolipoma versus hepatocellular carcinoma in the noncirrhotic liver on gadoxetic acid–enhanced mri: A diagnostic challenge.AJR Am. J. Roentgenol.2016207356257010.2214/AJR.15.1560227248975
    [Google Scholar]
  20. JeonT.Y. KimS.H. LimH.K. LeeW.J. Assessment of triple-phase CT findings for the differentiation of fat-deficient hepatic angiomyolipoma from hepatocellular carcinoma in non-cirrhotic liver.Eur. J. Radiol.201073360160610.1016/j.ejrad.2009.01.01019200676
    [Google Scholar]
  21. VickersA.J. ElkinE.B. Decision curve analysis: A novel method for evaluating prediction models.Med. Decis. Making200626656557410.1177/0272989X0629536117099194
    [Google Scholar]
  22. YangX. WangQ. ZhouX. ZhouH. JiaW. HuC. ChuJ. KongL. Retrospective analysis of hepatic perivascular epithelioid cell tumour (PEComa) in a single centre for clinical diagnosis and treatment clinical diagnosis and treatment of hepatic PEComa.Medicine202210125e2950610.1097/MD.000000000002950635758391
    [Google Scholar]
  23. CaiP. WuY. XieC. ZhangW. HanR. WuP. Hepatic angiomyolipoma: CT and MR imaging findings with clinical–pathologic comparison.Abdom. Imaging201338348248910.1007/s00261‑012‑9932‑022996326
    [Google Scholar]
  24. Arif-TwariH. KalbB. ChundruS. SharmaP. CostelloJ. GuessnerR.W. MartinD.R. MRI of hepatocellular carcinoma: an update of current practices.Diagn. Interv. Radiol.201420320922110.5152/dir.2014.1337024808419
    [Google Scholar]
  25. DeneckeT. SteffenI.G. AgarwalS. SeehoferD. KrönckeT. HänninenE.L. KrammeI.B. NeuhausP. SainiS. HammB. GrieserC. Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI.Eur. Radiol.20122281769177510.1007/s00330‑012‑2422‑522437921
    [Google Scholar]
  26. FernandesJ.L. RochitteC.E. T1 Mapping.Magn. Reson. Imaging Clin. N. Am.2015231253410.1016/j.mric.2014.08.00725476671
    [Google Scholar]
  27. JabbourT.E. LaganaS.M. LeeH. Update on hepatocellular carcinoma: Pathologists’ review.World J. Gastroenterol.201925141653166510.3748/wjg.v25.i14.165331011252
    [Google Scholar]
  28. BalciN.C. BefelerA.S. BienemanB.K. FattahiR. SaglamS. HavliogluN. Fat Containing HCC.Acad. Radiol.200916896396810.1016/j.acra.2009.02.01019386514
    [Google Scholar]
/content/journals/cmir/10.2174/0115734056269369231213102554
Loading
/content/journals/cmir/10.2174/0115734056269369231213102554
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test